The present disclosure provides co-crystals of a substituted glycine compound and a co-former compound of Formula (I):
compositions comprising such, and uses thereof in treating and/or reducing the risk for a neuropsychiatric disorder (e.g., schizophrenia, psychotic disorders, depressive disorders, suicidal ideation and/or behavior, obsessive compulsive disorder or Alzheimer's disease). Also provided herein are methods for preparing the co-crystals.
本公开提供了一种由取代甘
氨酸化合物和公共形成剂化合物(I)的共晶体,包括这种化合物的组合物,并用于治疗和/或减少神经精神障碍(例如,精神分裂症,精神病性障碍,抑郁症,自杀意念和/或行为,强迫症或阿尔茨海默病)的风险的用途。本文还提供了制备共晶体的方法。